Vice President-elect Kamala Harris.
ERIN SCOTT / AFP / Getty Images
Vice President-Elect Kamala Harris, announced on Twitter this Monday night that the future Administration led by Joe Biden “Will guarantee” the availability of a “safe and effective” COVID-19 vaccine, adding that it will be “free for all.”
The Biden-Harris administration will ensure that a safe and effective vaccine will be free for all.
— Kamala Harris (@KamalaHarris) December 1, 2020
Hand in hand with Harris’s message, in a video shared on Twitter by the official account of the presidential transition Biden-Harris, the president-elect, Joe Biden, urged citizens to be responsible and protect themselves from COVID-19.
We all have a role to play in beating this crisis—every decision matters. Every decision we make can save lives. pic.twitter.com/XrMZWoTaT4
— Biden-Harris Presidential Transition (@Transition46) November 30, 2020
At the same time, Biden also promised to use the powers of the federal government to fight the virus in the best possible way. The president-elect had also promised before the election that the vaccine would be free for all.
“Once we have a safe and effective vaccine, it has to be free for everyone, insured or not,” Biden said in a speech in Wilmington, Delaware, days before the presidential election.
The then Democratic candidate promised that if elected, he would order the federal government to buy in bulk “As many doses as necessary” so they could provide them for free to those without insurance or Medicaid coverage. “
Harris’s announcement comes a day after The American pharmaceutical company Moderna will announce that it is going to immediately ask the United States and Europe for authorization to commercialize its coronavirus vaccine, which in clinical trials has shown an efficacy of 94.1% in preventing the disease and 100% in preventing severe cases.
Moderna, which had already announced the results of the phase 3 clinical trials on November 16, became the second American company, after Pfizer, which is requesting emergency authorization to start selling its product, known as mRNA-1273.
Pfizer has said that expects to be able to manufacture 50 million doses in the remainder of 2020 and 1.3 billion more in 2021, while Moderna has said that it will have 20 million for use in the US this year and that it will produce between 500 and 1,000 million globally next, for which it will have the Swiss company Lonza and the Spanish company Rovi in the final process manufacturing.
Pfizer and its German partner BioNTech They assured this Tuesday that they already requested authorization to distribute their vaccine in Europe. If authorization is granted, the vaccine could be available there already this year, BioNTech aggregates.
The Spanish newspaper El País assures that the date indicated for the approval of the vaccine in Europe could be December 29, while for the Moderna this could happen on January 12 of next year.
Controversial Trump adviser resigns
Neuroradiologist Scott Atlas, one of the White House advisers on the coronavirus, resigned Monday from his post. Atlas was known for his controversial views that managed to influence the strategy of the outgoing president, Donald Trump.
Atlas resigned with a letter that he posted on his Twitter account the same week that his 130-day government contract ran out.
The advisor promoted theses such as the rapid reopening of schools and jobs, as well as that health authorities should not worry about infections among young or healthy people.
Some of the Atlas ideas that Trump embraced without scientific foundation were that the pandemic was about to end in the United States. or that there would be a vaccine available before the November 3 presidential election.
He also questioned the effectiveness of masks or social distancing to combat the spread of the virus. In mid-October, shortly before the elections, Twitter deleted a message that said: “The masks work: NO.”
According to a former White House official consulted by The Washington Post, Atlas “was the worst thing that happened to Trump in 2020 from a personnel perspective.”
With information from The country.
Digsmak is a news publisher with over 12 years of reporting experiance; and have published in many industry leading publications and news sites.